SI2512453T1 - Granule za farmacevtske preparate, metode in naprave za njihovo proizvodnjo - Google Patents

Granule za farmacevtske preparate, metode in naprave za njihovo proizvodnjo

Info

Publication number
SI2512453T1
SI2512453T1 SI201031345A SI201031345A SI2512453T1 SI 2512453 T1 SI2512453 T1 SI 2512453T1 SI 201031345 A SI201031345 A SI 201031345A SI 201031345 A SI201031345 A SI 201031345A SI 2512453 T1 SI2512453 T1 SI 2512453T1
Authority
SI
Slovenia
Prior art keywords
granules
production
methods
pharmaceutical preparations
preparations
Prior art date
Application number
SI201031345A
Other languages
English (en)
Inventor
Carsten Hoeg-Moller
Crilles Casper Larsen
Jorgen Wittendorff
Brigitte Nissen
Kenneth Manby Pedersen
Tue Hansen
Helle Poulsen
Original Assignee
Ferring B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42110308&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI2512453(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring B.V. filed Critical Ferring B.V.
Publication of SI2512453T1 publication Critical patent/SI2512453T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1694Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • A61K31/609Amides, e.g. salicylamide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SI201031345A 2009-12-18 2010-12-15 Granule za farmacevtske preparate, metode in naprave za njihovo proizvodnjo SI2512453T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09179877A EP2340812A1 (en) 2009-12-18 2009-12-18 Granules for pharmaceutical preparations, methods and apparatus for their production
PCT/EP2010/069733 WO2011073245A2 (en) 2009-12-18 2010-12-15 Granules for pharmaceutical preparations, methods and apparatus for their production
EP10793226.1A EP2512453B1 (en) 2009-12-18 2010-12-15 Granules for pharmaceutical preparations, methods and apparatus for their production

Publications (1)

Publication Number Publication Date
SI2512453T1 true SI2512453T1 (sl) 2017-02-28

Family

ID=42110308

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201031345A SI2512453T1 (sl) 2009-12-18 2010-12-15 Granule za farmacevtske preparate, metode in naprave za njihovo proizvodnjo

Country Status (27)

Country Link
US (2) US8765185B2 (sl)
EP (2) EP2340812A1 (sl)
JP (1) JP5593396B2 (sl)
KR (1) KR101882880B1 (sl)
CN (2) CN102791257B (sl)
AR (1) AR079536A1 (sl)
AU (1) AU2010332884B2 (sl)
BR (1) BR112012014935B1 (sl)
CA (1) CA2784235C (sl)
DK (1) DK2512453T3 (sl)
ES (1) ES2612870T3 (sl)
HR (1) HRP20161639T1 (sl)
HU (1) HUE031228T2 (sl)
IL (1) IL220319A (sl)
JO (1) JO3762B1 (sl)
LT (1) LT2512453T (sl)
MX (2) MX351365B (sl)
NL (1) NL1038373C2 (sl)
NZ (1) NZ600582A (sl)
PL (1) PL2512453T3 (sl)
PT (1) PT2512453T (sl)
RS (1) RS55438B1 (sl)
RU (1) RU2584349C2 (sl)
SI (1) SI2512453T1 (sl)
TW (1) TWI511723B (sl)
WO (1) WO2011073245A2 (sl)
ZA (1) ZA201204441B (sl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1615619A2 (en) * 2003-04-23 2006-01-18 Ferring B.V. Sachet for a pharmaceutical composition
WO2010040020A1 (en) 2008-10-02 2010-04-08 Salix Pharmaceuticals, Ltd. Methods of treating hepatic encephalopathy
EP2340812A1 (en) 2009-12-18 2011-07-06 Ferring International Center S.A. Granules for pharmaceutical preparations, methods and apparatus for their production
US20140141075A1 (en) 2012-11-21 2014-05-22 Warner Chilcott Company, Llc 5-aminosalicylic acid capsule formulation
DE202017102645U1 (de) * 2017-05-03 2018-08-06 Romaco Kilian Gmbh Ablaufvorrichtung für Presslinge einer Rundläufer-Tablettenpresse sowie Rundläufer-Tablettenpresse mit Ablaufvorrichtung
RU2667637C1 (ru) * 2017-06-26 2018-09-21 Гермес Арцнаймиттель ГмбХ Фармацевтическая композиция для перорального применения, содержащая n-ацетилцистеин с маскированным вкусом
ES2938608T3 (es) 2017-09-20 2023-04-13 Tillotts Pharma Ag Método para preparar una forma farmacéutica sólida que comprende anticuerpos mediante granulación en húmedo, extrusión y esferonización
EP3459529A1 (en) 2017-09-20 2019-03-27 Tillotts Pharma Ag Preparation of sustained release solid dosage forms comprising antibodies by spray drying
EP3459528B1 (en) 2017-09-20 2022-11-23 Tillotts Pharma Ag Preparation of solid dosage forms comprising antibodies by solution/suspension layering
KR102161235B1 (ko) * 2020-07-22 2020-09-29 주식회사 피티케이 이송 일체형 과립 제조 장치 및 방법
CN114472139A (zh) * 2022-01-04 2022-05-13 安徽宏信药业发展有限公司 一种中药药丸干燥筛选装置
CN115445902B (zh) * 2022-09-21 2023-06-06 重庆科技学院 一种条形颗粒物三维尺寸分选方法及装置
CN116942532B (zh) * 2023-09-20 2023-12-12 北京爱力佳医药科技有限公司 一种粉状药物制备装置

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981002671A1 (en) 1980-03-20 1981-10-01 Ferring Farma Lab Pharmaceutical composition and method for the treatment of colitis ulcerosa and crohn's disease by oral administration
DE3786544T2 (de) 1986-03-10 1994-02-03 Cri Int Inc Verfahren zur Sortierung und Isolierung von Katalysator-Formteilchen nach ihrer Länge.
US4720473A (en) * 1986-03-10 1988-01-19 Cri International, Inc. Production of improved catalyst-type particles using length and density grading
JPH0827133B2 (ja) 1993-07-13 1996-03-21 不二パウダル株式会社 湿潤粉粒体の処理装置
US6004581A (en) * 1995-12-21 1999-12-21 Farmaceutisk Laboratorium Ferring A/S Modified release oral pharmaceutical composition and method for the treatment of bowel diseases
TR199801158T2 (xx) 1995-12-21 1998-09-21 Farmaceutisk Laboratorium Ferring A/S Ba��rsak hastal�klar� i�in oral farmas�tik kompozisyon.
AUPO637197A0 (en) 1997-04-23 1997-05-15 F.H. Faulding & Co. Limited Taste-masked pharmaceutical compositions
DE19724181A1 (de) * 1997-06-09 1998-12-10 Bayer Ag Multiple-unit-retard-Zubereitungen und Verfahren zu ihrer Herstellung
JP2000128774A (ja) 1998-10-26 2000-05-09 Tanabe Seiyaku Co Ltd 薬物を含有する球形微粒子の製法
US6146685A (en) 1998-11-05 2000-11-14 Delsys Pharmaceutical Corporation Method of deposition a dry powder and dispensing device
WO2000044353A1 (de) * 1999-01-29 2000-08-03 Losan Pharma Gmbh Pharmazeutische zusammensetzungen
US6735487B1 (en) 1999-07-01 2004-05-11 Ods Properties, Inc. Interactive wagering system with promotions
GB0113841D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
CN100506234C (zh) 2001-10-15 2009-07-01 凡林有限公司 用于治疗溃疡性结肠炎和克罗恩病的含有5-氨基水杨酸的药物组合物的制备方法
AR036797A1 (es) 2001-10-15 2004-10-06 Ferring Bv Un metodo para preparar una composicion farmaceutica que comprende acido 5-aminosalicilico para utilizar en el tratamiento de colitis ulcerosa y enfermedades de crohn
US7445796B2 (en) 2002-08-19 2008-11-04 L. Perrigo Company Pharmaceutically active particles of a monomodal particle size distribution and method
EP1615619A2 (en) 2003-04-23 2006-01-18 Ferring B.V. Sachet for a pharmaceutical composition
EP1470819A1 (en) * 2003-04-23 2004-10-27 Ferring B.V. High drug load mesalazine sachet
EP1547601A1 (en) 2003-12-23 2005-06-29 Ferring B.V. Coating method
US7207505B2 (en) 2004-06-04 2007-04-24 Bender Martin P Method for producing small granules
DE102004028977A1 (de) * 2004-06-16 2006-01-05 Add Advanced Drug Delivery Technologies Ltd. Neutralpellets
WO2007061717A2 (en) 2005-11-17 2007-05-31 Teva Pharmaceutical Industries, Ltd. Methods for isolating propargylated aminoindans
EP2340812A1 (en) 2009-12-18 2011-07-06 Ferring International Center S.A. Granules for pharmaceutical preparations, methods and apparatus for their production

Also Published As

Publication number Publication date
MX2012006851A (es) 2012-08-31
US9114083B2 (en) 2015-08-25
MX351365B (es) 2017-10-12
US20130022681A1 (en) 2013-01-24
US8765185B2 (en) 2014-07-01
US20140328934A1 (en) 2014-11-06
AR079536A1 (es) 2012-02-01
PL2512453T3 (pl) 2017-03-31
TW201125556A (en) 2011-08-01
ZA201204441B (en) 2013-02-27
JO3762B1 (ar) 2021-01-31
TWI511723B (zh) 2015-12-11
WO2011073245A2 (en) 2011-06-23
RU2012124834A (ru) 2014-01-27
EP2340812A1 (en) 2011-07-06
JP2013514312A (ja) 2013-04-25
BR112012014935A2 (pt) 2016-03-08
IL220319A (en) 2016-03-31
NL1038373C2 (en) 2011-06-21
EP2512453A2 (en) 2012-10-24
AU2010332884B2 (en) 2015-12-10
DK2512453T3 (en) 2017-01-09
CA2784235A1 (en) 2011-06-23
WO2011073245A3 (en) 2011-08-11
ES2612870T3 (es) 2017-05-19
BR112012014935B1 (pt) 2021-12-21
IL220319A0 (en) 2012-08-30
PT2512453T (pt) 2016-12-16
NZ600582A (en) 2014-09-26
KR20120102775A (ko) 2012-09-18
CN105769772A (zh) 2016-07-20
RS55438B1 (sr) 2017-04-28
KR101882880B1 (ko) 2018-07-27
JP5593396B2 (ja) 2014-09-24
RU2584349C2 (ru) 2016-05-20
CN102791257B (zh) 2017-03-01
LT2512453T (lt) 2016-12-27
CN102791257A (zh) 2012-11-21
HUE031228T2 (en) 2017-07-28
HRP20161639T1 (hr) 2017-02-10
CA2784235C (en) 2019-01-15
AU2010332884A1 (en) 2012-07-05
EP2512453B1 (en) 2016-11-09

Similar Documents

Publication Publication Date Title
ZA201204441B (en) Granules for pharmaceutical preparations,methods and apparatus for their production
IL245050A0 (en) Optimum fc variants, pharmaceutical preparations and drugs containing them, and a method for their preparation
AP3724A (en) Security elements, and methods and apparatus for their manufacture
HK1161878A1 (en) Dihydropteridinone derivatives, preparation process and pharmaceutical use thereof
IL225597A0 (en) Pharmaceutical preparation, methods of treatment and its uses
ZA201300100B (en) Indolizine derivatives,process for the preparation thereof and therapeutic use thereof
EP2331074A4 (en) GRANULATE, PROCESS FOR ITS MANUFACTURE AND PHARMACEUTICAL PRODUCTS THEREWITH
SI2729151T1 (sl) Farmacevtski sestavek, postopki za zdravljenje in njihove uporabe
EP2570400A4 (en) PROCESS FOR PREPARING -SIALON, -SIALON, AND PRODUCT USING THE SAME
AP2012006526A0 (en) Germination-stimulant carbamate derivatives and process for preparation thereof
HRP20130832T1 (en) Chromone derivatives, a process for their preparation and their therapeutic applications
EP2436678A4 (en) TRIALLYLISOCYANURATE AND MANUFACTURING METHOD THEREFOR
HUP1000366A2 (en) Novel proteins, their production process and use tereof
ZA201309559B (en) Comptothecin derivative, method for preparing same, pharmaceutical composition and use thereof
HK1182656A1 (zh) 帶藥劑的支承體及其製造方法
IL219872A (en) Quinazoline derivatives, their uses, their preparation, and their medications
GB201014023D0 (en) Process for producing bioconjugates and products thereof
EP2616120A4 (en) ADMINISTRATION APPARATUS, METHOD OF OPERATION THEREFOR, AND METHOD OF ADMINISTRATION
EP2586463A4 (en) PHARMACEUTICAL MULTIMERE PARTICLES AND METHOD FOR THE PRODUCTION THEREOF
EP2415467A4 (en) METHOD FOR PRODUCING A UBICHINONE POWDER FOR USE IN PREPARATIONS AND PRODUCTS THEREOF
ZA201108148B (en) Triazine-aryl-bis-indoles and process for preparation thereof
HUP0900305A2 (en) Peptide derivatives, process for their preparation and their therapeutical use
GB201020398D0 (en) Potash product, method and apparatus